Switzerland Supplementary Protection Certificates
✉ Email this page to a colleague
Supplementary Protection Certificates
Country | Patent Number | Supplementary Protection Certificate | SPC Country | SPC Description | SPC Expiration |
---|---|---|---|---|---|
European Patent Office | 1506211 | C01506211/01 | Switzerland | PRODUCT NAME: DAPAGLIFLOZIN; REGISTRATION NO/DATE: SWISSMEDIC 65176 19.08.2014 | ⤷ Try a Trial |
European Patent Office | 3347352 | C03347352/01 | Switzerland | PRODUCT NAME: LENACAPAVIR; REGISTRATION NO/DATE: SWISSMEDIC-ZULASSUNG 68386 07.07.2023 | ⤷ Try a Trial |
European Patent Office | 2404919 | C02404919/01 | Switzerland | PRODUCT NAME: 3-(6-((1-(2,2-DIFLUOR-1,3-BENZODIOXOL-5-YL)CYCLOPROPANCARBONYL)AMINO)-3-METHYLPYRIDIN-2-YL)BENZOESAEURE (LUMACAFTOR); REGISTRATION NO/DATE: SWISSMEDIC-ZULASSUNG 65981 02.09.2016 | ⤷ Try a Trial |
European Patent Office | 1734971 | C01734971/01 | Switzerland | PRODUCT NAME: EXENATIDE; REGISTRATION NO/DATE: SWISSMEDIC 61629 17.02.2012 | ⤷ Try a Trial |
European Patent Office | 1135391 | C01135391/01 | Switzerland | FORMER REPRESENTATIVE: BOHEST AG, CH | ⤷ Try a Trial |
>Country | >Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Description | >SPC Expiration |